We are pleased to announce the winners of the One Nucleus Awards 2026! The awards took place on 29 March in London.
The One Nucleus Award categories are structured to reflect that breadth of R&D, investment, service provision and enabling support across the stakeholders.
Many congratulations to the winners and finalists:
Best Therapeutic R&D Programme of the Year
⭐Winner: Resolution Therapeutics⭐
Finalists: Serenatis Bio, TRIMTECH Therapeutics
New parliamentary scrutiny of the UK’s innovation landscape has reinforced longstanding concerns about how investment in innovation is distributed across the country, with Pioneer Group, a specialist in technology infrastructure and venture building, urging swift action to address persistent barriers to research commercialisation.
Who we are:
Life, Reimagined
Constructive Bio is a VC-backed biotechnology startup based in Whittlesford, Cambridge. Our unique technology turns living cells into biofactories, creating sustainable new materials and therapeutics. With full control of the genetic sequence and code, we are exploring chemical space previously unreached by natural biology.
About Sygnature Discovery
At Sygnature Discovery, we create exceptional scientific outcomes. For our customers, who bring life-changing medicines to patients; and for our people, who help make this possible.
We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment.
Introduction to role:
Are you ready to lead API analytics that accelerate novel oncology medicines from concept to candidate selection and ultimately to reach patients? Do you thrive at the interface of LC-MS science, digital enablement, and cross-functional decision-making to unlock clearer, faster answers?
In this webinar, you will learn how to protect your organisation and clients against rising cyber threats, using AI and automation to enhance resilience while reducing operational costs.
Building and maintaining a Security Operations Centre (SOC) can cost upwards of £2 million. Managed Detection and Response (MDR) is rapidly becoming the default model for resilient, cost-effective cyber defence, delivering the same enterprise-grade security capabilities as a fully staffed SOC at a fraction of the cost.
— Financing brings total funds committed to date to >$95 million
— Proceeds support the STARLYS clinical trial evaluating targeted LTBR agonist MST-0312 in solid tumors, together with platform and pipeline activities in inflammatory diseases
— Expands the leadership team with exceptional development executives to propel the clinical advancement of the pipeline
Your role
We are looking to recruit an expert structural biologist with an experimental background to join the EMDB as a biocurator within the EMBL-EBI OneDep data curation team.
About Us
The Spatial Biology Facility is co-led by Professor Anita Grigoriadis and Dr Ciro Chiappini, based in the Guy’s Cancer Centre at King’s College London (KCL).
Spatial multiomics approaches reveal how cells interact and organise across different tissue landscape. Having secured large-scale funding in this field, we have built a spatial core facility to utilise the nanoString CosMx Digital Spatial Profiler and 10x Genomics Xenium Analyzer for high-resolution, imaging-based in situ spatial profiling.
About The Role